Fate Therapeutics Inc (FATE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -41.057 | -42.879 | -41.843 | -38.093 | -37.5 | -27.482 | -34.63 | -26.561 |
Return on Equity (%) | -60.19 | -57.139 | -56.045 | -48.442 | -55.113 | -39.905 | -48.457 | -37.761 |
Return on Invested Capital (%) | -51.518 | -50.341 | -50.932 | -53.571 | -45.667 | -47.673 | -61.043 | -47.11 |
Operating Margin (%) | -722.967 | -1015.197 | -1369.241 | -902.594 | -551.591 | -379.886 | -292.545 | -253.298 |
Net Profit Margin (%) | -760.177 | -1046.079 | -1405.021 | -918.998 | -551.591 | -379.886 | -292.545 | -253.298 |
Book Value Per Share | 1.183 | 1.056 | 2.377 | 3.116 | 4.247 | 6.89 | 4.835 | 3.635 |
Earnings Per Share | -0.541 | -0.587 | -0.986 | -1.25 | -1.916 | -2.153 | -2.815 | -1.588 |
Cash Per Share | 1.433 | 1.217 | 2.822 | 1.271 | 1.849 | 1.356 | 0.613 | 0.413 |
Working Capital Per Share | 1.263 | 1.252 | 2.635 | 2.537 | 4.516 | 5.604 | 3.877 | 2.885 |
Operating Profit Per Share | 0.071 | 0.056 | 0.07 | 0.136 | 0.347 | 0.567 | 0.962 | 0.627 |
EBIT Per Share | -0.541 | -0.587 | -0.986 | -1.25 | -1.916 | -2.153 | -2.815 | -1.588 |
EBITDA Per Share | -0.541 | -0.587 | -0.986 | -1.25 | -1.916 | -2.153 | -2.815 | -1.588 |
Free Cash Flow Per Share | -0.548 | -0.577 | -0.97 | -1.183 | -1.895 | -1.699 | -2.597 | -1.707 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 41,39M | 52,65M | 64,69M | 75,73M | 87,72M | 95,73M | 97,3M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 97,3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -32.013 | N/A | N/A | N/A | -2493.714 | N/A | N/A |
Net Profit Margin (%) | N/A | -32.013 | N/A | N/A | N/A | -2493.714 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 203,87M |
Ratio cours/bénéfice | -1,25 |
Ratio prix/ventes | 3,16 |
Ratio prix/liquidités | 4,79 |
Ratio prix/valeur comptable | 0,54 |
Rendement de dividende | - |
Actions en circulation | 113,89M |
Volume moyen (1 semaine) | 3,01M |
Volume moyen (1 mois) | 3,63M |
Variation sur 52 semaines | -50,84% |
Plus haut sur 52 semaines | 8,83 |
Plus bas sur 52 semaines | 1,55 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales